🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taho Pharmaceuticals Ltd. (TPE:6467)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
204.00
-20.50 (-9.13%)
At close: Nov 19, 2026

Taho Pharmaceuticals Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10,6915,7302,274120120120
Market Cap Growth
21.31%151.98%1789.98%0%0%-80.46%
Enterprise Value
10,4505,3432,074393939
Last Close Price
204.00111.5044.352.302.302.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1880.24681.34-112.8718.9217.47
PB Ratio
39.8113.524.410.581.311.87
P/TBV Ratio
39.8913.554.410.581.311.87

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-635.26-36.816.175.70

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.030.030.11-0.08
Net Debt / Equity Ratio
-0.82-0.89-0.93-1.01-1.15-1.19
Net Debt / EBITDA Ratio
1.081.752.851.761.841.17
Net Debt / FCF Ratio
1.231.812.891.941.6722.63
Asset Turnover
0.020.02-0.010.05-
Quick Ratio
13.7015.0115.023.852.296.36
Current Ratio
13.7915.1215.093.912.396.42
Return on Equity (ROE)
-63.21%-45.62%-46.32%-80.79%-84.84%-
Return on Assets (ROA)
-37.55%-27.08%-25.20%-35.89%-33.66%-
Return on Capital Employed (ROCE)
-78.00%-51.20%-32.20%-54.20%-72.50%-77.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-2.14%-3.74%-7.36%-100.30%-55.10%-9.52%
FCF Yield
-1.67%-3.65%-7.29%-89.02%-52.87%-2.80%
Buyback Yield / Dilution
-3.59%-13.40%-17.18%-7.73%-3.77%33.75%